102 related articles for article (PubMed ID: 2761343)
21. Protection and rescue from 2',3'-dideoxypyrimidine nucleoside analog toxicity by hemin in human bone marrow progenitor cells.
Fowler DA; Xie MY; Sommadossi JP
Antimicrob Agents Chemother; 1996 Jan; 40(1):191-5. PubMed ID: 8787904
[TBL] [Abstract][Full Text] [Related]
22. Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides.
Van Draanen NA; Tisdale M; Parry NR; Jansen R; Dornsife RE; Tuttle JV; Averett DR; Koszalka GW
Antimicrob Agents Chemother; 1994 Apr; 38(4):868-71. PubMed ID: 7518218
[TBL] [Abstract][Full Text] [Related]
23. A comparison of three nucleoside analogs with anti-retroviral activity on immune and hematopoietic functions in mice: in vitro toxicity to precursor cells and microstromal environment.
Luster MI; Germolec DR; White KL; Fuchs BA; Fort MM; Tomaszewski JE; Thompson M; Blair PC; McCay JA; Munson AE
Toxicol Appl Pharmacol; 1989 Nov; 101(2):328-39. PubMed ID: 2554533
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the in vitro toxicity of 2',3'-dideoxynucleosides to murine hematopoietic progenitor cells.
Du DL; Volpe DA; Grieshaber CK; Murphy MJ
Int J Cell Cloning; 1992 Mar; 10(2):87-93. PubMed ID: 1545153
[TBL] [Abstract][Full Text] [Related]
25. Effects of 2',3'-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis.
Faraj A; Fowler DA; Bridges EG; Sommadossi JP
Antimicrob Agents Chemother; 1994 May; 38(5):924-30. PubMed ID: 7520683
[TBL] [Abstract][Full Text] [Related]
26. In vitro anti-human immunodeficiency virus activity of 2',3'-dideoxynucleosides and their effect on clonal growth of hemopoietic cells from human bone marrow.
Cinatl J; Cinatl J; Rabenau H; Gümbel H; Doerr HW
Arzneimittelforschung; 1993 May; 43(5):622-5. PubMed ID: 8329011
[TBL] [Abstract][Full Text] [Related]
27. Dipyridamole potentiates the inhibition by 3'-azido-3'-deoxythymidine and other dideoxynucleosides of human immunodeficiency virus replication in monocyte-macrophages.
Szebeni J; Wahl SM; Popovic M; Wahl LM; Gartner S; Fine RL; Skaleric U; Friedmann RM; Weinstein JN
Proc Natl Acad Sci U S A; 1989 May; 86(10):3842-6. PubMed ID: 2542948
[TBL] [Abstract][Full Text] [Related]
28. 3'-Azido-3'-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells.
Dainiak N; Worthington M; Riordan MA; Kreczko S; Goldman L
Br J Haematol; 1988 Jul; 69(3):299-304. PubMed ID: 3261597
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.
Hamamoto Y; Nakashima H; Matsui T; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1987 Jun; 31(6):907-10. PubMed ID: 3039911
[TBL] [Abstract][Full Text] [Related]
30. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.
Chen CH; Vazquez-Padua M; Cheng YC
Mol Pharmacol; 1991 May; 39(5):625-8. PubMed ID: 1851960
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of CFU-E/BFU-E by 3'-azido-3'-deoxythymidine, chlorpropamide, and protoporphirin IX zinc (II): a comparison between direct exposure of progenitor cells and long-term exposure of bone marrow cultures.
Gribaldo L; Malerba I; Collotta A; Casati S; Pessina A
Toxicol Sci; 2000 Nov; 58(1):96-101. PubMed ID: 11053545
[TBL] [Abstract][Full Text] [Related]
32. Myelotoxicity of rifabutin and 3'-azido-3'-deoxythymidine, alone and in combination, to human hematopoietic progenitor cells in vitro.
Volpe DA; Du DL; Verhoef V; Murphy MJ
Pathobiology; 1993; 61(2):77-82. PubMed ID: 8216829
[TBL] [Abstract][Full Text] [Related]
33. Influence of interleukin-3 (IL-3) on the hematopoietic toxicity associated with combination anti-viral drugs (zidovudine and DDI) in vitro using retrovirus-infected bone marrow cells.
Gallicchio VS; Hughes NK
Int J Immunopharmacol; 1994 Apr; 16(4):359-66. PubMed ID: 8045675
[TBL] [Abstract][Full Text] [Related]
34. Amelioration of zidovudine-induced fetal toxicity in pregnant mice.
Gogu SR; Beckman BS; Agrawal KC
Antimicrob Agents Chemother; 1992 Nov; 36(11):2370-4. PubMed ID: 1489179
[TBL] [Abstract][Full Text] [Related]
35. Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements.
Gillespie D; Hubbell HR; Carter WA; Midgette P; Elsasser W; Mullaney R; Strayer DR
In Vivo; 1994; 8(3):375-81. PubMed ID: 7803722
[TBL] [Abstract][Full Text] [Related]
36. Reversal of azidothymidine-induced bone marrow suppression by 2',3'-dideoxythymidine as studied by hemopoietic clonal culture.
Yoshida Y; Yoshida C
AIDS Res Hum Retroviruses; 1990 Jul; 6(7):929-32. PubMed ID: 2390336
[TBL] [Abstract][Full Text] [Related]
37. Effective modulation of the haematopoietic toxicity associated with zidovudine exposure to murine and human haematopoietic progenitor stem cells in vitro with lithium chloride.
Gallicchio VS; Hughes NK
J Intern Med; 1992 Mar; 231(3):219-26. PubMed ID: 1313488
[TBL] [Abstract][Full Text] [Related]
38. Influence of interleukin-3 on zidovudine (AZT)-induced in vitro toxicity to human hematopoietic progenitors.
Gallicchio VS; Hughes NK
Int J Cell Cloning; 1992 Mar; 10(2):99-104. PubMed ID: 1545155
[TBL] [Abstract][Full Text] [Related]
39. 2'3'-Dideoxycytidine-induced thymic lymphoma correlates with species-specific suppression of a subpopulation of primitive hematopoietic progenitor cells in mouse but not rat or human bone marrow.
Irons RD; Le AT; Som DB; Stillman WS
J Clin Invest; 1995 Jun; 95(6):2777-82. PubMed ID: 7539460
[TBL] [Abstract][Full Text] [Related]
40. Antiretroviral activity, biochemistry, and pharmacokinetics of 3'-azido-2',3'-dideoxy-5-methylcytidine.
Schinazi RF; Chu CK; Eriksson BF; Sommadossi JP; Doshi KJ; Boudinot FD; Oswald B; McClure HM
Ann N Y Acad Sci; 1990; 616():385-97. PubMed ID: 1706574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
